11
Views
4
CrossRef citations to date
0
Altmetric
Original Article

The Anticonvulsant Effect of Deprenyl on Pentylenetetrazol-Induced Seizures in Lewis Rats

, , &
Pages 223-232 | Received 24 Feb 1997, Published online: 07 Jul 2009

References

  • Al-Tajir G., Starr M. S. D2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D2 receptors in the striatum but not in the substantia nigra. Pharmacology Biochemistry & Behavior 1991; 39: 109–113
  • Alam A. M., Starr M. S. Effects of dopamine D3 receptors on pilocarpine-induced limbic seizures in the rat. Neuroscience 1994; 60: 1039–1047
  • Burley E. S., Ferrendel J. A. Regulatory effects of neurotransmitters on electroshock and pentylenetetrazol seizures. Federation Proceedings 1984; 43: 2521–2524
  • Corcoran M. E., Fibiger H. C., McGeer E. G., Wada J. A. Potentiation of leptazol seizures by 6-hydroxydopamine. Journal of Pharmacy and Pharmacology 1973; 25: 497–499
  • Hoffman A., Afargan M., Gilhar D. Deprenyl exhibits an anticonvulsant activity in pentylenetetrazol (PTZ) model in rats. Pharmaceutical Research 1993; 10: 359
  • Hoffman A., Alfon J. High-dose methotrexate does not affect the pharmacodynamics of phenobarbital hypnotic action but decreases the central nervous system (CNS) sensitivity to pentylenetetrazol-induced maximal seizures in rats. Pharmaceutical Research 1992; 9: 1295–1298
  • Killam E. K., Killam K. F. Evidence for neurotransmitter abnormalities related to seizure activity in the epileptic baboon. Federation Proceedings 1984; 43: 2510–2515
  • Knoll J. The possible mechanism of action of deprenyl in Parkinson's disease. Journal of Neural Transmission 1978; 43: 177–198
  • Knoll J. Deprenyl (Selegiline, Movrgan) facilitates the activity of the nigrostriatal dopaminergic neuron. Journal of Neural Transmission 1987; 25: 45–66
  • Knoll J. The pharmacological profile of (-)deprenyl (selegiline) and its relevance for humans: A personal view. Pharmacology and Toxicology 1992; 70: 317–321
  • Loscher W., Honack D. Anticonvulsant and antiepileptic effect of L-deprenyl (Selegiline) in the kindling model of epilepsy. Journal of Pharmacology and Experimental Therapeutics 1995; 274: 307–314
  • Mangoni A. Effects of MAO-B inhibitor in the treatment of Alzheimer disease. European Neurology 1991; 31: 100–107
  • Meldrum B., Anlezark G., Trimble M. Drugs modifying dopaminergic activity and behaviour, the EEG and epilepsy in Papio Papio. European Journal of Pharmacology 1975; 32: 203–213
  • Mendlewicz J., Youdim M. B. Deprenyl, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double-blind evaluation. British Journal of Psychiatry 1983; 142: 508–511
  • Ramzan I. M., Levy G. Kinetics of drug action in disease states. XIV. Effect of infusion rate on pentylenetetrazol concentrations in serum, brain and cerebrospinal fluid of normal rats at onset of convulsions. Journal of Pharmacology and Experimental Therapeutics 1985; 234: 717–721
  • Starr M. S., Starr B. S. Seizure promotion by D-1 agonists does not correlate with other dopaminergic properties. Journal of Neural Transmission 1993; 6: 27–34
  • Swinyard A., Brown C. Comparative assays of antiepileptic drugs in mice and rats. Journal of Pharmacology and Experimental Therapeutics 1952; 106: 319–330
  • Turski L., Cavalherio E. A., Turski W. A., Meldrum B. S. Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine and N-methyl-D-aspartate. Neuroscience 1986; 18: 61–77
  • Warter J., Vergenes M., Depaulis A., Tranchant C., Rumbach L., Mecheletti G., Marescaux C. Effects of drugs affecting dopaminergic neurotransmission in rats with spontaneous petit mal seizures. Neuropharmacology 1989; 27: 269–274
  • Woodbury. Antiepileptic Drugs: Mechanisms of action. Raven Press, New York 1980
  • Yahr M. R-(-)-Deprenyl and Parkinsonism. Journal of Neural Transmission 1987; 25: 5–12
  • Youdim M. B., Riederer P. The glycine-prodrug, Milacemide, increases the seizure threshold due to hyperbaric oxygen; prevention by deprenyl. European Journal of Pharmacology 1988; 150: 381–384
  • Zsilla G., Foldi P., Held G., Szekely A. M., Knoll J. The effect of repeated doses of (-)deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline. Polish Journal of Pharmacology and Pharmacy 1986; 38(1)57–67

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.